102 related articles for article (PubMed ID: 7535370)
1. Growth inhibition of malignant CD5+B (B-1) cells by antisense IL-10 oligonucleotide.
Peng B; Mehta NH; Fernandes H; Chou CC; Raveché E
Leuk Res; 1995 Mar; 19(3):159-67. PubMed ID: 7535370
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation and down-regulation of cell surface and mRNA expression of CD5 antigen by various humoral factors on murine 70Z/3 pre-B cell leukemia cell line: IL-4 down-regulates CD5 antigen expression.
Jyonouchi H; Voss RM; Good RA
Cell Immunol; 1990 Oct; 130(1):66-78. PubMed ID: 1697787
[TBL] [Abstract][Full Text] [Related]
3. Cell cycle effects of IL-10 on malignant B-1 cells.
Yen Chong S; Lin YC; Czarneski J; Zhang M; Coffman F; Kashanchi F; Raveche E
Genes Immun; 2001 Aug; 2(5):239-47. PubMed ID: 11528515
[TBL] [Abstract][Full Text] [Related]
4. Endogenous secretion of IL-4 maintains growth and Thy-1 expression of a transformed B cell clone.
Louie SW; Ramirez LM; Krieg AM; Maliszewski CR; Bishop GA
J Immunol; 1993 Jan; 150(2):399-406. PubMed ID: 8093458
[TBL] [Abstract][Full Text] [Related]
5. Regulatory role of T cells in a murine model of lymphoproliferative disease.
Raveche E; Fernandes H; Ong H; Peng B
Cell Immunol; 1998 Jul; 187(1):67-75. PubMed ID: 9682005
[TBL] [Abstract][Full Text] [Related]
6. Raf-1 protein is required for growth factor-induced proliferation of hematopoietic cells.
Muszynski KW; Ruscetti FW; Heidecker G; Rapp U; Troppmair J; Gooya JM; Keller JR
J Exp Med; 1995 Jun; 181(6):2189-99. PubMed ID: 7539043
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-10 is an autocrine growth factor for acquired immunodeficiency syndrome-related B-cell lymphoma.
Masood R; Zhang Y; Bond MW; Scadden DT; Moudgil T; Law RE; Kaplan MH; Jung B; Espina BM; Lunardi-Iskandar Y
Blood; 1995 Jun; 85(12):3423-30. PubMed ID: 7780129
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 antisense oligonucleotides inhibit the growth of human myeloma cell lines.
Levy Y; Tsapis A; Brouet JC
J Clin Invest; 1991 Aug; 88(2):696-9. PubMed ID: 1864979
[TBL] [Abstract][Full Text] [Related]
9. Reversible inhibition of IL-8 receptor B mRNA expression and proliferation in non-small cell lung cancer by antisense oligonucleotides.
Olbina G; Cieslak D; Ruzdijic S; Esler C; An Z; Wang X; Hoffman R; Seifert W; Pietrzkowski Z
Anticancer Res; 1996; 16(6B):3525-30. PubMed ID: 9042216
[TBL] [Abstract][Full Text] [Related]
10. The correlation of telomerase and IL-10 with leukemia transformation in a mouse model of chronic lymphocytic leukemia (CLL).
Peng B; Zhang M; Sun R; Lin YC; Chong SY; Lai H; Stein D; Raveche ES
Leuk Res; 1998 Jun; 22(6):509-16. PubMed ID: 9678717
[TBL] [Abstract][Full Text] [Related]
11. Evidence for internal autocrine regulation of growth in acute myeloblastic leukemia cells.
Rogers SY; Bradbury D; Kozlowski R; Russell NH
Exp Hematol; 1994 Jul; 22(7):593-8. PubMed ID: 7516889
[TBL] [Abstract][Full Text] [Related]
12. RNA interference of IL-10 in leukemic B-1 cells.
McCarthy BA; Mansour A; Lin YC; Kotenko S; Raveche E
Cancer Immun; 2004 Jul; 4():6. PubMed ID: 15270555
[TBL] [Abstract][Full Text] [Related]
13. Requirement for increased IL-10 in the development of B-1 lymphoproliferative disease in a murine model of CLL.
Ramachandra S; Metcalf RA; Fredrickson T; Marti GE; Raveche E
J Clin Invest; 1996 Oct; 98(8):1788-93. PubMed ID: 8878429
[TBL] [Abstract][Full Text] [Related]
14. Effect of IL-6 receptor antisense oligodeoxynucleotide on in vitro proliferation of myeloma cells.
Keller ET; Ershler WB
J Immunol; 1995 Apr; 154(8):4091-8. PubMed ID: 7706747
[TBL] [Abstract][Full Text] [Related]
15. Growth inhibition of human glioma cells modulated by retrovirus gene transfection with antisense IL-8.
Yamanaka R; Tanaka R; Yoshida S; Saitoh T; Fujita K
J Neurooncol; 1995; 25(1):59-65. PubMed ID: 8523090
[TBL] [Abstract][Full Text] [Related]
16. Oligonucleotides antisense to the interleukin 1 receptor mRNA block the effects of interleukin 1 in cultured murine and human fibroblasts and in mice.
Burch RM; Mahan LC
J Clin Invest; 1991 Oct; 88(4):1190-6. PubMed ID: 1833422
[TBL] [Abstract][Full Text] [Related]
17. Specific inhibition of interleukin-10 production in murine macrophage-like cells by phosphorothioate antisense oligonucleotides.
Arima H; Takahashi M; Aramaki Y; Sakamoto T; Tsuchiya S
Antisense Nucleic Acid Drug Dev; 1998 Aug; 8(4):319-27. PubMed ID: 9743469
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression.
Lu C; Kerbel RS
J Cell Biol; 1993 Mar; 120(5):1281-8. PubMed ID: 8436594
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of IL-2 hyper-responsive NZB/WF1 CD5- B cells.
Hirose S; Nakanishi K; Yoshimoto T; Kashiwamura S; Hiroishi K; Matsumoto H; Hamaoka T; Shinka S; Higashino K
J Immunol; 1994 Aug; 153(4):1847-57. PubMed ID: 7519217
[TBL] [Abstract][Full Text] [Related]
20. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor.
Schadendorf D; Möller A; Algermissen B; Worm M; Sticherling M; Czarnetzki BM
J Immunol; 1993 Sep; 151(5):2667-75. PubMed ID: 8360485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
